GlobeNewsWire · CRC · October 20, 2026

Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option

Get the app for more

Explore stock news, insights and company research.